Trial
NCT04936841
Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Wisconsin, Madison
Collaborators
Nektar Therapeutics
Condition
Head and Neck Cancer
Intervention
NKTR-214
Why stopped
study closed by the sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-04